Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Onyx Pharma CFO plugs cancer pipeline amid rumored sales process
Fierce Biotech
Fri, 01/13/12 - 09:29 am
ONYX Pharmaceuticals
Pfizer
Takeda
M&A
cancer
Nexavar
Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc.
Yahoo
Fri, 01/13/12 - 09:27 am
Inhibitex
tender offer
M&A
Bristol-Myers Squibb
AtriCure again cited by an analyst as likely acquisition target
Thu, 01/12/12 - 11:00 pm
ArtiCure
M&A
Inhibitex Shareholders Sue Over Bristol’s $2.5 Billion Offer
Bloomberg
Thu, 01/12/12 - 10:07 pm
shareholders
M&A
Inhibitex
Bristol-Myers Squibb
Europe’s Drugmakers May Boost Acquisitions After Buyback Focus
Bloomberg Businessweek
Thu, 01/12/12 - 02:11 pm
Europe
M&A
patents
GSK
Roche
AstraZeneca
Novartis
Abbott says no bid on rival Pfizer's baby, infant nutrition business
Crain's Chicago Business, IL
Thu, 01/12/12 - 09:17 am
Abbott Laboratories
infant nutrition
Pfizer
M&A
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thu, 01/12/12 - 08:29 am
M&A
Pharmasset
Gilead
Boston Scientific CEO says sees significant future capacity for acquisitions
Wed, 01/11/12 - 10:40 pm
Boston Scientific
CEO
M&A
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wed, 01/11/12 - 12:58 pm
M&A
Roche
Sanofi
Bristol-Myers Squibb
Novartis
Pfizer
Merck
Sanofi CEO Is Open to Deals of Up to $2.6 Billion This Year
Bloomberg
Wed, 01/11/12 - 10:55 am
Sanofi
Pharma CEOs
M&A
Chris Viehbacher
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
hepatitis C
Inhibitex
Bristol-Myers Squibb
Gilead
Pharmasset
M&A
JPM kicks off with fevered focus on the next big biotech deal
Fierce Biotech
Mon, 01/9/12 - 10:42 am
JPMorgan
biotech
M&A
Inhibitex
Bristol-Myers Squibb
Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bloomberg
Mon, 01/9/12 - 10:12 am
Bristol-Myers Squibb
M&A
Inhibitex
hepatitis C
Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Mon, 01/9/12 - 09:57 am
hepatitis C
Bristol-Myers Squibb
M&A
Inhibitex
Gilead
Pharmasset
S&P: Bristol-Myers announcement will not affect rating
Reuters
Mon, 01/9/12 - 09:53 am
Bristol-Myers Squibb
M&A
Inhibitex
Bristol-Myers to Acquire Inhibitex for $2.5 Billion
NY Times, NY
Mon, 01/9/12 - 09:15 am
Bristol-Myers Squibb
Inhibitex
M&A
The Law Office of James C. Kelly Announces Investigation of Inhibitex, Inc.
Yahoo/PR NewsWire
Sun, 01/8/12 - 12:44 pm
Inhibitex
Bristol-Myers Squibb
M&A
Bristol to buy Inhibitex for hepatitis C treatment
Reuters
Sun, 01/8/12 - 12:45 pm
INX-189
Inhibitex
hepatitis C
Bristol-Myers Squibb
M&A
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
Yahoo/BusinessWire
Sat, 01/7/12 - 01:23 pm
Gilead Sciences
Pharmasset
M&A
Amgen, big biotechs poised for big year of deals, analysts say
Fierce Pharma
Fri, 01/6/12 - 01:37 pm
Amgen
biotech
M&A
Celgene
Pages
« first
‹ previous
…
250
251
252
253
254
255
256
257
258
…
next ›
last »